Cas:887596-92-1 (1-bromonaphthalen-2-yl)methanamine manufacturer & supplier

We serve Chemical Name:(1-bromonaphthalen-2-yl)methanamine CAS:887596-92-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(1-bromonaphthalen-2-yl)methanamine

Chemical Name:(1-bromonaphthalen-2-yl)methanamine
CAS.NO:887596-92-1
Synonyms:2-Naphthalenemethanamine,1-bromo
Molecular Formula:C11H10BrN
Molecular Weight:236.10800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.03000
Exact Mass:235.00000
LogP:3.71700

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Naphthalenemethanamine,1-bromo chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Naphthalenemethanamine,1-bromo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Naphthalenemethanamine,1-bromo Use and application,2-Naphthalenemethanamine,1-bromo technical grade,usp/ep/jp grade.


Related News: SAN FRANCISCO–(BUSINESS WIRE)–BetterUp, the inventor of virtual coaching and the first to democratize professional coaching across the entire enterprise, announced today that it is putting down roots in Europe with two new offices in Munich and London. 2-Thiazolamine, 4-(4-methoxyphenyl)-N-phenyl-5-(3-pyridinyl)- manufacturers “This approval strengthens our product offering in the US and we look forward to the launch of generic Baclofen in due course.” [3-(azetidin-1-ylmethyl)phenyl]-(2,4-dimethylphenyl)methanone suppliers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. Cyclohexyl-methyl-(2-triethylsilanyloxy-ethyl)-amine vendor & factory.